Company intelligence / Profile preview

Viona Pharmaceuticals

Cranford, New Jersey, United Statesvionausa.com ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

Viona Pharmaceuticals markets and distributes a broad portfolio of FDA-approved generic oral solid and topical products in the United States. The company continues to expand its pipeline with additional generics under development. No proprietary clinical results are reported as it operates in the generics sector.

Therapeutic areas: Metabolic DisordersDermatologyCardiovascularNeurologyInfectious Diseases
Modalities: Small molecules (oral solids and topicals/generics)
Industry: Biotech

Drug pipeline

3 assets

tretinoin

Commercial

Indications: Acne

2 more assets in the full pipeline.

Request access →

Partnerships

Parent-subsidiary relationship with Zydus Lifesciences Limited; no major external partnerships disclosed.

Beyond the preview

Go deeper on Viona Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viona Pharmaceuticals.

Explore the full profile